Skip to main content
Top
Published in: International Urology and Nephrology 1/2009

01-03-2009 | Urology - Original Paper

Health-related quality of life after hand-assisted laparoscopic and open radical nephrectomies of renal cell carcinoma

Authors: Jianping Jiang, Xiangyi Zheng, Jie Qin, Mingzhi Zheng, Qiqi Mao, Zhigen Zhang, Songliang Cai, Liping Xie

Published in: International Urology and Nephrology | Issue 1/2009

Login to get access

Abstract

Aim

To compare the health-related quality of life (HRQOL) in contemporaneous groups of patients undergoing hand-assisted laparoscopic radical nephrectomy (HALRN) or open radical nephrectomy (ORN) for renal cell carcinoma (RCC).

Patients and methods

The clinical data of 20 cases receiving hand-assisted laparoscopic radical nephrectomy (the HALRN group) and 51 cases receiving open radical nephrectomy (the ORN group) were analyzed retrospectively and health questionnaires were mailed to these patients at 1 year postoperatively. The two groups were compared in terms of general surgery-related information, tumor characteristics, days to return to work or routine daily activities, and health-related quality-of-life scales.

Results

Patients in the HALRN group had significantly less mean incision length (6.25 versus 17.8 cm), faster return to work or routine daily activities (5.3 versus 8.6 weeks), and earlier out-of-bed activity (4.76 versus 6.59 days) compared with those in the ORN group (P < 0.05). There were no significant differences in HRQOL scales at 1 year between the both groups (P > 0.05).

Conclusion

The results showed that hand-assisted laparoscopic surgery is a minimally invasive surgical technique for RCC offering earlier recovery and similar long-term HRQOL compared with open surgery.
Literature
1.
go back to reference Robson CJ, Churchill BM, Anderson W (1969) The results of radical nephrectomy for renal cell carcinoma. J Urol 101:297–301PubMed Robson CJ, Churchill BM, Anderson W (1969) The results of radical nephrectomy for renal cell carcinoma. J Urol 101:297–301PubMed
2.
go back to reference Clayman RV, Kavoussi LR, Soper NJ et al (1991) Laparoscopic nephrectomy: initial case report. J Urol 146:278–282PubMed Clayman RV, Kavoussi LR, Soper NJ et al (1991) Laparoscopic nephrectomy: initial case report. J Urol 146:278–282PubMed
12.
go back to reference Mols F, van de Poll-Franse LV, Vingerhoets AJ et al (2006) Long-term quality of life among Dutch prostate cancer survivors: results of a population-based study. Cancer 107:2186–2196. doi:10.1002/cncr.22231 PubMedCrossRef Mols F, van de Poll-Franse LV, Vingerhoets AJ et al (2006) Long-term quality of life among Dutch prostate cancer survivors: results of a population-based study. Cancer 107:2186–2196. doi:10.​1002/​cncr.​22231 PubMedCrossRef
14.
Metadata
Title
Health-related quality of life after hand-assisted laparoscopic and open radical nephrectomies of renal cell carcinoma
Authors
Jianping Jiang
Xiangyi Zheng
Jie Qin
Mingzhi Zheng
Qiqi Mao
Zhigen Zhang
Songliang Cai
Liping Xie
Publication date
01-03-2009
Publisher
Springer Netherlands
Published in
International Urology and Nephrology / Issue 1/2009
Print ISSN: 0301-1623
Electronic ISSN: 1573-2584
DOI
https://doi.org/10.1007/s11255-008-9429-5

Other articles of this Issue 1/2009

International Urology and Nephrology 1/2009 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.